Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
new york top stories
3
×
biotech
boston blog main
boston top stories
breast cancer
clinical trials
glaxosmithkline
national top stories
new york
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
acute migrane
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
amgen
amicus therapeutics
anylam pharmaceuticals
arvinas
bain capital
batten disease
bausch health
bayer
biogen
boulder/denver blog main
boulder/denver top stories
brian stuglik
cancer diagnostics
cancer immunotherapy
cardiomyopathy
What
drug
3
×
pfizer
3
×
patients
acquisitions
activity
ago
akcea
albert
alnylam
amyloidosis
approved
attr
available
battle
biggest
bio
biotech
bourla
ceo
companies
company
crispr
days
debilitating
disease
dog
fda
firm
future
genetic
hasn’t
imports
ipo
ipos
leading
line
maker
maps
measured
medicines
Language
unknown
unset
Current search:
drug
×
pfizer
×
" new york top stories "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
